Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis

Amir B. Orandi, Vikas R. Dharnidharka, Noor Al-Hammadi, Kevin W. Baszis

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Background: Few risk factors have been identified for the development of calcinosis among patients with Juvenile Dermatomyositis, and currently no clinical phenotype has been associated with its development. We analyzed a large database of patients to further elucidate any relationships among patients with and without calcinosis. Method: The CARRA legacy registry recruited pediatric rheumatology patients from 55 centers across North America from 2010 through 2014, including over 650 subjects with Juvenile Dermatomyositis. We compared the demographic characteristics, clinical disease features and treatment histories of those with and without calcinosis using univariate and multivariate logistic regression. Results: Of the 631 patients included in the analysis, 84 (13%) had a current or prior history of calcinosis. These patients were statistically more likely to have longer durations of disease prior to diagnosis and treatment, have lipodystrophy and joint contractures, and to have received intravenous immune globulin or rituximab as treatments. Conclusions: Calcinosis is found more often in patients with prolonged active disease, severe disease, and certain clinical features such as lipodystrophy and joint contractures. When these factors are combined with other known associations and predictors, groups of at-risk patients can be more effectively identified, treated and studied to improve overall outcomes.

Original languageEnglish
Article number84
JournalPediatric Rheumatology
Volume16
Issue number1
DOIs
StatePublished - Dec 29 2018

Keywords

  • Biologics
  • Calcinosis
  • Juvenile dermatomyositis
  • Pediatric rheumatology

Fingerprint Dive into the research topics of 'Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis'. Together they form a unique fingerprint.

Cite this